Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
Revenues | 9,228.9 | 6,454.4 | 4,345.9 | 4,166.8 |
Revenue growth | 43.0% | 48.5% | 4.3% | |
Cost of goods sold | 8,634.1 | 6,105.3 | 4,012.3 | 3,864.3 |
Gross profit | 594.7 | 349.1 | 333.6 | 302.5 |
Gross margin | 6.4% | 5.4% | 7.7% | 7.3% |
Selling, general and administrative | 511.0 | 360.4 | 270.1 | 259.8 |
Sales and marketing | 19.3 | 10.6 | 5.3 | 5.8 |
EBITA | 120.2 | -1.3 | 107.4 | 95.1 |
EBITA margin | 1.3% | 0.0% | 2.5% | 2.3% |
Amortization of intangibles | 10.9 | 11.4 | 11.5 | 11.5 |
EBIT | 109.3 | -12.7 | 95.8 | 83.6 |
EBIT margin | 1.2% | -0.2% | 2.2% | 2.0% |
Pre-tax income | 70.9 | -44.6 | 59.1 | 42.8 |
Income taxes | -34.1 | -13.3 | 18.1 | 10.3 |
Tax rate | | 29.9% | 30.7% | 24.1% |
Net income | 86.5 | -7.2 | 52.5 | 55.1 |
Net margin | 0.9% | -0.1% | 1.2% | 1.3% |
|
Diluted EPS | $0.91 | ($0.10) | $0.94 | $0.99 |
Shares outstanding (diluted) | 94.9 | 72.2 | 55.6 | 55.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|